Industry Ignited Podcast ยท 2026-08-07 ยท 1h 3m
What does it really take to bring a life-saving medical breakthrough to patients? In this episode of Industry Ignited , Dr. Leeanne Aguilar sits down with Dr. Michael Weickert, CEO of Pacylex Pharmaceuticals and FE Pharmaceuticals, to discuss the realities of building first-in-class therapies in oncology and infectious disease. From the challenges of securing funding for breakthrough innovations to navigating clinical development and investor skepticism, Dr. Weickert shares decades of experience leading biotech companies focused on transforming patient care. The conversation explores the future of cancer treatment, groundbreaking approaches to combating antibiotic resistance, and why some of the most promising medical discoveries struggle to gain traction. Whether you're an entrepreneur, investor, healthcare professional, or simply curious about the future of medicine, this episode offers valuable insights into the science, strategy, and persistence required to bring revolutionary therapies to life. ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ ๐ง๐ข๐ญ๐๐ ๐๐ง๐ฌ๐ญ๐๐ ๐ซ๐๐ฆ ๐ ๐๐๐๐๐จ๐จ๐ค ๐๐ข๐ง๐ค๐๐๐๐ง ๐๐ฉ๐จ๐ญ๐ข๐๐ฒ ๐๐ฉ๐ฉ๐ฅ๐ ๐๐จ๐๐๐๐ฌ๐ญ ๐๐ซ.
Other episodes covering the same guests and topics, from across The B2B Podcast Index.
Why Reshoring Could Be More Profitable Than Offshoring | Ep. 107 [Harry Moser]88 / 100This Surgical Innovation Solves a 50-Year-Old Problem | Ep. 98 [Will Crawford]80 / 100The Next Billion-Dollar Energy Opportunity | Ep. 92 [Andrew Stock]70 / 100How to Scale a Battery Energy Storage Company Without Failing | Ep. 91 [Mark Hagedorn]65 / 100How Manufacturers Are Cutting Energy Costs Without Spending a Dollar Upfront | Ep. 90 [David Kipling]71 / 100
